about
C-galactosylceramide: Synthesis and immunologyTurned on by danger: activation of CD1d-restricted invariant natural killer T cellsRole of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseHuman and Mouse Type I Natural Killer T Cell Antigen Receptors Exhibit Different Fine Specificities for CD1d-Antigen ComplexStructural and Functional Characterization of a Novel Nonglycosidic Type I NKT Agonist with Immunomodulatory PropertiesRecognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptorImproving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsRaising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.Stimulation of natural killer T cells by glycolipidsSynthesis and Biological Activities of 5-Thio-α-GalCers.Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation.The Crotylation Way to Glycosphingolipids: Synthesis of Analogues of KRN7000.C-Glycosphingolipids with an exo-methylene substituent: stereocontrolled synthesis and immunostimulation of mouse and human natural killer T lymphocytes.Recognition of CD1d-restricted antigens by natural killer T cells.The versatility of the αβ T-cell antigen receptor.Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.Strategy of lipid recognition by invariant natural killer T cells: 'one for all and all for one'.Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues.The CD1 family: serving lipid antigens to T cells since the Mesozoic era.Monoclonal Invariant NKT (iNKT) Cell Mice Reveal a Role for Both Tissue of Origin and the TCR in Development of iNKT Functional Subsets.Selective Conditions Are Required for the Induction of Invariant NKT Cell Hyporesponsiveness by Antigenic Stimulation.A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses.The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis.Differing roles of CD1d2 and CD1d1 proteins in type I natural killer T cell development and function.
P2860
Q24625835-B7CB8089-6CA5-499B-99C3-C1E9FED04C13Q26825059-5B2FD000-11B9-4A50-A637-2CDF5D50CE04Q26996330-2430838A-C463-4461-8FF7-97518A7EDB38Q27673493-0DC384C2-9220-40D6-B9CA-CAF0CC2706E8Q27677017-1E087091-6D37-47C9-ACFE-2B45E4BC5DCFQ27681807-30AF71E7-C371-4E8E-894F-3FB329B78D8CQ28543248-161C554D-1677-4D19-9F2E-F35FBA06C41BQ30408873-60A1E289-1F2C-4C60-B701-4A1E6A14707EQ33599059-795EB1AF-1FF0-4315-AEBC-8150B9FDEC8DQ35559790-B3CC2BC7-F16F-4918-AD38-0BE169F8000DQ35837120-EE769EC1-923C-4FA8-806D-F8FDF5167CE5Q36112680-40FDF229-C9D9-45F7-A359-E359CB17E6FAQ36225616-C8E5C0B0-CFB9-4C94-B7EF-AE049DF1C07EQ37088000-0AE333E8-355E-423D-8154-7D7DF615E6F4Q37623478-194E3A71-95BE-41B9-B634-9743D0492FCDQ37986831-8575C4F6-A9EF-4563-A756-6FE09DBDCCFBQ38016483-BFBCAAFB-BA0D-48AD-AEC1-271AD6E3EB95Q38050484-2E746DEB-E29F-4B48-B3E0-1C0D4DD786AEQ38862782-83C46292-FF0D-4DC7-AA48-8A3527F84FA2Q38883512-E612AF6B-65E0-4067-B143-051434F4179CQ40174608-D98BA22A-6F5C-46FB-AA8C-1D8728B713E4Q40556221-66EB685B-74F1-473A-816D-5EF546F6E09FQ40832140-FDCC1505-8805-46EE-B334-DBCDB5CBBAB4Q44851304-FAEF1581-5DD6-4226-91AF-A710615F56A0Q47877699-B90A8731-85B8-4A3B-95E3-95972016A02AQ49912553-8E1160BC-067A-4727-B24E-5B2F8717C4D6
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
NKT TCR Recognition of CD1d- -C-Galactosylceramide
@ast
NKT TCR Recognition of CD1d- -C-Galactosylceramide
@en
NKT TCR Recognition of CD1d- -C-Galactosylceramide
@nl
type
label
NKT TCR Recognition of CD1d- -C-Galactosylceramide
@ast
NKT TCR Recognition of CD1d- -C-Galactosylceramide
@en
NKT TCR Recognition of CD1d- -C-Galactosylceramide
@nl
prefLabel
NKT TCR Recognition of CD1d- -C-Galactosylceramide
@ast
NKT TCR Recognition of CD1d- -C-Galactosylceramide
@en
NKT TCR Recognition of CD1d- -C-Galactosylceramide
@nl
P2093
P2860
P50
P356
P1476
NKT TCR recognition of CD1d-α-C-galactosylceramide
@en
P2093
Garth Cameron
Hoe-Sup Byun
Onisha Patel
Richard W Franck
Robert Bittman
Steven A Porcelli
Youssef Harrak
P2860
P304
P356
10.4049/JIMMUNOL.1100794
P407
P50
P577
2011-09-30T00:00:00Z